ARD podcast   /     Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

Description

In this podcast, we invite two authors from recent ARD papers dedicated to the efficacy of mRNA vaccines in patients with immunosuppressive therapies. Christophe Richez, Department of Rheumatology, University Medical Center, Bordeaux, France, and ARD's Social Media Advisor, interviews Bimba Hoyer, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Germany, and Rebecca H Haberman, Division of Rheumatology, University Grossman School of Medicine, New York, USA. They describe their works and offer their thoughts on the current situation in this area and the future. Related content: https://ard.bmj.com/content/early/2021/05/11/annrheumdis-2021-220272 https://ard.bmj.com/content/early/2021/06/07/annrheumdis-2021-220597

Subtitle
In this podcast, we invit...
Duration
20:37
Publishing date
2021-07-29 17:01
Link
http://feeds.bmj.com/~r/ard/podcasts/~3/6ELaeuQ0EgM/immunogenicity-of-anti-sars-cov-2-mrna-vaccines-in-patients-with-rheumatic-diseases
Contributors
  BMJ talk medicine
author  
Enclosures
http://feeds.bmj.com/~r/ard/podcasts/~5/8hSMVXc1rdY/1096438897-bmjgroup-immunogenicity-of-anti-sars-cov-2-mrna-vaccines-in-patients-with-rheumatic-diseases.mp3
audio/mpeg